Venous thromboembolic disease: Clinical practice guidelines in Oncology™ Review uri icon


MeSH Major

  • Medical Oncology
  • Thromboembolism
  • Venous Thrombosis


  • Recognizing the increased risk of VTE in cancer patients is the first step in preventing the occurrence of VTE and promptly identifying the disease in cancer patients. The NCCN panel recommends VTE thromboprophylaxis for all hospitalized patients with cancer who do not have contraindications to such therapy, and the panel also emphasizes that an increased level of clinical suspicion of VTE should be maintained for cancer patients. Careful evaluation and follow-up of cancer patients in whom VTE is suspected and prompt treatment and follow-up for patients diagnosed with VTE is recommended after the cancer status of the patient and the risks and benefits of treatment are considered. © Journal of the National Comprehensive Cancer Network.

publication date

  • October 2006



  • Review



  • eng

PubMed ID

  • 17020664

Additional Document Info

start page

  • 838

end page

  • 69


  • 4


  • 9